CoTherix
https://www.cotherix.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From CoTherix
VCs Back ObsEva With $35M For Trials On Pre-term Labor Drug
The Swiss start-up will conduct a Phase II study on a compound that may reduce or prevent pre-term labor contractions, licensed from Merck Serono. It hopes to follow in the footsteps of another women's health company, PregLem, which provided exceptional returns with the same CEO and similar investors.
New Products In Brief
The latest product approvals and launches.
Start-Up News
Noteworthy news from medtech start-ups. This month we profile Magellan Spine Technologies, which aims to improve disc annular repair and r4 vascular, which is developing biomimetic-coated catheters.
Start-Up Previews (04/2010)
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, "Despite Challenges, Congestive Heart Failure Draws A Crowd," features profiles of miRagen, NellOne Therapeutics, Phrixus Pharmaceuticals and Sorbent Therapeutics. Plus these Start-Ups Across Health Care: Ambicare, Anulex Technologies, NeoTract and Sistemic.
Company Information
- Industry
-
Pharmaceuticals
- Generic Drugs
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice